Antiretroviral therapy for prevention is a combination strategy

Curr HIV/AIDS Rep. 2013 Jun;10(2):152-8. doi: 10.1007/s11904-013-0152-1.

Abstract

In the past several years, the debate of "treatment vs prevention" has shifted with the introduction of the concept of "treatment as prevention," (TasP), stemming from a series of compelling observational, ecological, and modeling studies as well as HPTN 052, a randomized clinical trial, demonstrating that use of ART is associated with a decrease in HIV transmission. In addition to TasP being viewed as 1 intervention in a combination strategy for HIV Prevention, TasP is, in and of itself, a combination of multiple interventions that need to be implemented with high coverage in order to achieve its potential impact.

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Circumcision, Male / statistics & numerical data*
  • Combined Modality Therapy
  • Counseling
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • Health Services Accessibility
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Male
  • Medication Adherence / statistics & numerical data
  • Primary Prevention*
  • Randomized Controlled Trials as Topic
  • Risk Reduction Behavior
  • United States / epidemiology

Substances

  • Anti-HIV Agents